Debbie Bowen-Heaton's, partner at Oliver Wight, provides an Expert View on how companies can prepare for the disruption Amazon's arrival in Europe's pharmaceuti 23 March 2021
Generics and biosimilars trade group Medicines for Europe has issued a statement calling for the expedition of digital regulatory infrastructure for medicines. 19 February 2021
The pharmaceutical industry is now frequently the number one target of cybercriminals around the world, as drugmakers move toward increased digitization and sto 9 February 2021
Novartis’ Steven Baert, chief people and organization officer, and Elizabeth Theophille, chief technology transformation officer, provide an Expert View predict 19 January 2021
Research from industry analyst GlobalData has found that established players in Japan’s immunology market have a dominant lead in the digital marketing space. 15 December 2020
The European pharmaceutical industry has thrown its weight behind the use of artificial intelligence (AI) in drug development, with the publication of a new pap 3 December 2020
British artificial intelligence specialist InstaDeep and German biotech firm BioNTech have deepened ties, embarking on a multi-year project to develop novel imm 25 November 2020
An Expert View from Karen Noonan at the Association of Clinical Research Organizations (ACRO) on adopting a more flexible approach to trials moving forward, som 28 September 2020
At the annual congress of the European Society of Medical Oncology (ESMO), taking place virtually, Johnson & Johnson’s pharma arm Janssen hopes to raise the bar 17 September 2020
Pierre-Georges Roy, partner at M&A advisor Results International, provides an Expert View on why deals kept being made even as much of society shut down. 18 August 2020
Developments in artificial intelligence (AI) and machine learning (ML) are playing an increasingly influential role in the biotech space, driving the formation 3 August 2020
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.